SCHEMBL27709

SCHEMBL27709

Cc1[c]cc(F)cc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL510184 0.80 ACHE (0.40)
SCHEMBL3518 0.71
SCHEMBL7101528 0.71
SCHEMBL22594 0.71
SCHEMBL457326 0.68 TAAR1 (0.48)
SCHEMBL15653904 0.67
SCHEMBL456581 0.67
SCHEMBL16167251 0.67 ACHE (0.31)
SCHEMBL16166891 0.67 ACHE (0.31)
SCHEMBL597407 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1545 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240228468-A1 N-(6-((OCTAHYDROCYCLOPENTA[C]PYRROL-5-YI)AMINO)PYRIDAZIN-3-YL)PHENYL)CARBOXAMIDE AND (6- ((OCTAHYDROCYCLOPENTA[C]PYRROL-5-YL)AMINO)PYRIDAZIN-3-YL)BENZAMIDE DERIVATIVES AS MACHR M4 ANTAGONISTS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS VANDERBILT UNIVERSITY 2024-07-11 US claimed
US-20240208902-A1 CYCLOBUTYL AMIDE MONOACYLGLYCEROL LIPASE MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2024-06-27 US claimed
WO-2024115549-A1 ARYL- AND HETEROARYL-SULFONAMIDE DERIVATIVES AS CCR8 MODULATORS IDORSIA PHARMACEUTICALS LTD (CH) 2024-06-06 WO claimed
US-20240174655-A1 INDAZOLE DERIVATIVES AS ANTAGONISTS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4 VANDERBILT UNIVERSITY 2024-05-30 US claimed
US-11987588-B2 Modulators of the beta-3 adrenergic receptor useful for the treatment or prevention of heart failure and disorders related thereto ARENA PHARMACEUTICALS, INC. (US) 2024-05-21 US claimed
CN-115197087-B Polysubstituted cyclobutene derivative and preparation method thereof 华东师范大学 2024-05-17 CN claimed
EP-4330247-A1 COMPOUNDS AND THEIR USES AS CD38 INHIBITORS Nanjing Immunophage Biotech Co., Ltd (CN) 2024-03-06 EP claimed
US-20240002344-A1 COMPOUNDS, COMPOSITIONS AND METHODS FOR HISTONE LYSINE DEMETHYLASE INHIBITION FIBROGEN, INC. 2024-01-04 US claimed
WO-2023239709-A2 TARGETING AN ENZYME REQUIRED FOR ACUTE MYELOID LEUKEMIA ALBERT EINSTEIN COLLEGE OF MEDICINE (US) 2023-12-14 WO claimed
US-11802111-B2 Cyclobutyl amide monoacylglycerol lipase modulators JANSSEN PHARMACEUTICA NV (BE) 2023-10-31 US claimed
EP-0535548-A1 Inhibitor of atherosclerotic intimal thickening NISSAN CHEMICAL INDUSTRIES LTD. (JP) 1993-04-07 EP claimed
US-5189169-A Postemergence herbicides IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1993-02-23 US claimed
US-5024999-A Anti-hyperlipidemia, anti-atherosclerosis agents NISSAN CHEMICAL INDUSTRIES LTD. (JP) 1991-06-18 US claimed
CN-1038279-A PYRAZOLOPYRIDINE TYPE MEVALONOLACTONES NISSAN CHEMICAL IND LTD (JP) 1989-12-27 CN claimed
EP-0339358-A1 Pyrazolopyridine type mevalonolactones NISSAN CHEMICAL INDUSTRIES LTD. (JP) 1989-11-02 EP claimed
WO-1989010365-A1 PYRAZOLOPYRIDINE TYPE MEVALONOLACTONES NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 1989-11-02 WO claimed
EP-0091193-B1 ANTIDIABETIC COMPOSITIONS PFIZER INC. (US) 1986-05-21 EP claimed
EP-0091193-A2 Antidiabetic compositions PFIZER INC. (US) 1983-10-12 EP claimed
EP-0007986-B1 SUBSTITUTED 2-PHENYLAMINO-IMIDAZOLINES-(2), THEIR ACID ADDITION SALTS, MEDICAMENTS CONTAINING THEM AND PROCESSES FOR THEIR PREPARATION C.H. BOEHRINGER SOHN (DE) 1981-09-16 EP claimed
US-4239764-A FOR SLOWING HEART RATE BOEHRINGER INGELHEIM GMBH (DE) 1980-12-16 US claimed